Search by Drug Name or NDC
NDC 50222-0346-02 Adbry 150 mg/mL Details
Adbry 150 mg/mL
Adbry is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by LEO Pharma Inc.. The primary component is TRALOKINUMAB.
MedlinePlus Drug Summary
Tralokinumab injection is used to treat moderate to severe eczema (atopic dermatitis; a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes) in adults who cannot use topical medications for their condition or whose eczema has not responded to topical medications. Tralokinumab is in a class of medications called interleukin-13 receptor inhibitors. It works by blocking the activity of interleukin-13, a substance in the body that causes inflammation.
Related Packages: 50222-0346-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tralokinumab-ldrm injection
Product Information
NDC | 50222-0346 |
---|---|
Product ID | 50222-346_5b709bae-6a5c-4a83-8bb1-83c8069d8086 |
Associated GPIs | 9027308045E520 |
GCN Sequence Number | 082945 |
GCN Sequence Number Description | tralokinumab-ldrm SYRINGE 150 MG/ML SUBCUT |
HIC3 | V4G |
HIC3 Description | INTERLEUKIN-13 (IL-13) INHIBITORS, MAB |
GCN | 51749 |
HICL Sequence Number | 047741 |
HICL Sequence Number Description | TRALOKINUMAB-LDRM |
Brand/Generic | Brand |
Proprietary Name | Adbry |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | tralokinumab-ldrm |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | SUBCUTANEOUS |
Active Ingredient Strength | 150 |
Active Ingredient Units | mg/mL |
Substance Name | TRALOKINUMAB |
Labeler Name | LEO Pharma Inc. |
Pharmaceutical Class | Interleukin-13 Antagonist [EPC], Interleukin-13 Antagonists [MoA] |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA761180 |
Listing Certified Through | 2024-12-31 |
Package
NDC 50222-0346-02 (50222034602)
NDC Package Code | 50222-346-02 |
---|---|
Billing NDC | 50222034602 |
Package | 2 SYRINGE, GLASS in 1 CARTON (50222-346-02) / 1 mL in 1 SYRINGE, GLASS (50222-346-01) |
Marketing Start Date | 2022-01-02 |
NDC Exclude Flag | N |
Pricing Information | N/A |